TERRA TECH CORP. (OTCMKTS:TRTC) Files An 8-K Regulation FD DisclosureItem 7.01Regulation FD Disclosure.
On June 4, 2018, Terra Tech Corp. (the “Company”) issued a press release announcing that Derek Peterson, Chief Executive Officer, will present live at VirtualInvestorConferences.com on June 7, 2018. A copy of the press release is attached hereto as Exhibit99.1 and is incorporated herein by reference.
The information contained in this Item 7.01, and in Exhibit 99.1, referenced herein is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act or incorporated by reference in any filing under the Securities Act, unless the Company expressly so incorporates such information by reference.
Item 7.01 Financial Statements and Exhibits.
(d)Exhibits:
|
Exhibit |
Description |
|
99.1 |
Press Release, dated June 4, 2018 |
Terra Tech Corp. ExhibitEX-99.1 2 trtc_ex991.htm PRESS RELEASE trtc_ex991.htmEXHIBIT 99.1 Terra Tech Corp. to Webcast,…To view the full exhibit click here
About TERRA TECH CORP. (OTCMKTS:TRTC)
Terra Tech Corp. is a cannabis-focused agriculture company. The Company operates through two segments: Hydroponic Produce and Cannabis Products. The Company, through its subsidiary, GrowOp Technology Ltd., is engaged in the design, marketing and sale of hydroponic equipment. It is also a retail seller of locally grown hydroponic produce, herbs, and floral products through its subsidiary, Edible Garden Corp. (Edible Garden). It intends to operate medical marijuana cultivation, production and dispensary facilities in Nevada through its subsidiaries, MediFarm, LLC (MediFarm), MediFarm I, LLC (MediFarm I) and MediFarm II, LLC (MediFarm II). Through its subsidiary, IVXX, Inc. (IVXX), it produces and sells a line of cannabis flowers and cigarettes, among others. The hydroponic produce segment consists of Edible Garden’s business and operations. Its cannabis products segment consists of IVXX’s business, as well as the proposed business operations of MediFarm, MediFarm I and MediFarm II.